Skip to main content
. 2022 Sep 8;11(3):58. doi: 10.3390/antib11030058

Figure 10.

Figure 10

Illustration of the role of mAb W6/32 in enhancing the CD2 and CD3 mediated activation of T-cells (A) as well as the role of HLA-I polyreactive mAbs TFL-006 and TFL-007 in suppression of (PHA)-CD3-mediated activation of T lymphocytes (B) [125,126,127,128,129,130,131].